发布求助
文献互助 智能选刊 最新文献

Nanomedicine (London, England)最新文献

筛选
英文 中文
Novel Tubeimoside I liposomal drug delivery system in combination with gemcitabine for the treatment of pancreatic cancer. 新型 Tubeimoside I 脂质体给药系统与吉西他滨联合治疗胰腺癌。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-09-03 DOI: 10.1080/17435889.2024.2382076
Shuhui Li, Yuansheng Liu, Xiaojun Sui, Yuzhen Zhuo, He Siqi, Zhang Sijia, Zhang Hui, Li Dihua, Zhang Dapeng, Yang Lei
{"title":"Novel Tubeimoside I liposomal drug delivery system in combination with gemcitabine for the treatment of pancreatic cancer.","authors":"Shuhui Li, Yuansheng Liu, Xiaojun Sui, Yuzhen Zhuo, He Siqi, Zhang Sijia, Zhang Hui, Li Dihua, Zhang Dapeng, Yang Lei","doi":"10.1080/17435889.2024.2382076","DOIUrl":"10.1080/17435889.2024.2382076","url":null,"abstract":"<p><p><b>Aim:</b> To evaluate the anti-pancreatic cancer effect of novel Tubeimoside I multifunctional liposomes combined with gemcitabine.<b>Methods:</b> Liposomes were prepared through the thin film hydration method, with evaluations conducted on parameters including encapsulation efficiency (EE%), particle size, polydispersity index (PDI), zeta potential (ZP), storage stability, and release over a 7-day period. The cellular uptake rate, therapeutic efficacy <i>in vitro</i> and <i>in vivo</i> and the role of immune microenvironment modulation were evaluated.<b>Results:</b> The novel Tubeimoside I multifunctional liposomal exhibited good stability, significant anti-cancer activity, and immune microenvironment remodeling effects. Furthermore, it showed a safety profile.<b>Conclusion:</b> This study underscores the potential of Novel Tubeimoside I multifunctional liposomal as a promising treatment option for pancreatic cancer.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142121284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sol-gel synthesis of magnesium oxide nanoparticles and their evaluation as a therapeutic agent for the treatment of osteoarthritis. 氧化镁纳米粒子的溶胶凝胶合成及其作为骨关节炎治疗剂的评估。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-08-07 DOI: 10.1080/17435889.2024.2382421
Sen Mei, Fangchao Jiang, Na Liu, Zhizi Feng, Yu Zheng, Wei Yang, Weizhong Zhang, Yingna Cui, Weiming Wang, Jin Xie, Nan Zhang
{"title":"Sol-gel synthesis of magnesium oxide nanoparticles and their evaluation as a therapeutic agent for the treatment of osteoarthritis.","authors":"Sen Mei, Fangchao Jiang, Na Liu, Zhizi Feng, Yu Zheng, Wei Yang, Weizhong Zhang, Yingna Cui, Weiming Wang, Jin Xie, Nan Zhang","doi":"10.1080/17435889.2024.2382421","DOIUrl":"10.1080/17435889.2024.2382421","url":null,"abstract":"<p><p><b>Aim:</b> We synthesized MgO NPs via sol-gel reaction and investigated them as carriers to deliver Mg<sup>2+</sup> to the affected joint for osteoarthritis (OA).<b>Materials & methods:</b> The physicochemical properties of samples were characterized by transmission electron microscope (TEM), dynamic light scattering (DLS) and x-ray diffraction (XRD). The release of Mg<sup>2+</sup> was monitored by ICP-MS. The potential cytotoxicity was evaluated using MTT assay. The efficacy and biosafety were evaluated in a rabbit OA model.<b>Results:</b> MgO NPs can prolong the Mg<sup>2+</sup> release time from 0.5 h to 12 h. No significant cytotoxicity was observed when concentrations below 250 μg/ml. Intra-articular samples could effectively alleviate the degeneration and destruction of the cartilage.<b>Conclusion:</b> this study demonstrates the potential of MgO NPs as a safe and effective treatment of OA. Simultaneously, the size of the particles may play a significant role in influencing the therapeutic outcome.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457622/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141899084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing radiotherapy for melanoma: the promise of high-Z metal nanoparticles in radiosensitization. 加强黑色素瘤的放射治疗：高 Z 值金属纳米粒子在放射增敏方面的前景。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-10-09 DOI: 10.1080/17435889.2024.2403325
Abolfazl Bemidinezhad, Shaghayegh Radmehr, Negin Moosaei, Zohreh Efati, Prashant Kesharwani, Amirhossein Sahebkar
{"title":"Enhancing radiotherapy for melanoma: the promise of high-Z metal nanoparticles in radiosensitization.","authors":"Abolfazl Bemidinezhad, Shaghayegh Radmehr, Negin Moosaei, Zohreh Efati, Prashant Kesharwani, Amirhossein Sahebkar","doi":"10.1080/17435889.2024.2403325","DOIUrl":"10.1080/17435889.2024.2403325","url":null,"abstract":"<p><p>Melanoma is a type of skin cancer that can be challenging to treat, especially in advanced stages. Radiotherapy is one of the main treatment modalities for melanoma, but its efficacy can be limited due to the radioresistance of melanoma cells. Recently, there has been growing interest in using high-Z metal nanoparticles (NPs) to enhance the effectiveness of radiotherapy for melanoma. This review provides an overview of the current state of radiotherapy for melanoma and discusses the physical and biological mechanisms of radiosensitization through high-Z metal NPs. Additionally, it summarizes the latest research on using high-Z metal NPs to sensitize melanoma cells to radiation, both <i>in vitro</i> and <i>in vivo</i>. By examining the available evidence, this review aims to shed light on the potential of high-Z metal NPs in improving radiotherapy outcomes for patients with melanoma.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mineralo-organic particles inhibit influenza A virus infection by targeting viral hemagglutinin activity. 矿物有机微粒通过靶向病毒血凝素活性抑制甲型流感病毒感染。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-09-25 DOI: 10.1080/17435889.2024.2403326
Huan-Jung Chiang, Hsin-Hsin Peng, Kuo-Feng Weng, Kuei-Ching Hsiung, Chieh-Yu Liang, Shun-Li Kuo, David M Ojcius, John Ding-E Young, Shin-Ru Shih
{"title":"Mineralo-organic particles inhibit influenza A virus infection by targeting viral hemagglutinin activity.","authors":"Huan-Jung Chiang, Hsin-Hsin Peng, Kuo-Feng Weng, Kuei-Ching Hsiung, Chieh-Yu Liang, Shun-Li Kuo, David M Ojcius, John Ding-E Young, Shin-Ru Shih","doi":"10.1080/17435889.2024.2403326","DOIUrl":"10.1080/17435889.2024.2403326","url":null,"abstract":"<p><p><b>Aim:</b> Mineralo-organic particles, naturally present in human body fluids, participate in ectopic calcification and inflammatory diseases. These particles coexist with influenza A virus (IAV) in the same microenvironment during viral infection. Our objective was to investigate the functional consequences of the potential interactions between these particles and the virions.<b>Materials & methods:</b> We used <i>in vitro</i> models, including electron microscopy, fluorescence microscopy, hemagglutination assay and viral infection assays to examine the interactions.<b>Results:</b> Mineralo-organic particles bind to IAV virions through interactions involving particle-bound fetuin-A and mineral content, effectively engaging viral hemagglutinin. These interactions result in hindered viral infection.<b>Conclusion:</b> These findings uncover the novel interactions between mineralo-organic particles and IAV, highlighting the impact of virus microenvironment complexity.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanoparticles for the treatment of inflammatory conditions. 用于治疗炎症的纳米颗粒。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-01-17 DOI: 10.2217/nnm-2023-0324
Christina Janko, Mehtap Civelek, Iwona Cicha, Helmut Spielvogel, Harald Unterweger, Christoph Alexiou
{"title":"Nanoparticles for the treatment of inflammatory conditions.","authors":"Christina Janko, Mehtap Civelek, Iwona Cicha, Helmut Spielvogel, Harald Unterweger, Christoph Alexiou","doi":"10.2217/nnm-2023-0324","DOIUrl":"10.2217/nnm-2023-0324","url":null,"abstract":"","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139479183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanomedicine-mediated drug delivery for potential treatment of inflammatory bowel disease: a narrative review. 纳米药物介导的药物输送用于炎症性肠病的潜在治疗：综述。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-01-29 DOI: 10.2217/nnm-2023-0267
Zhina Majdzadeh Ardekani, Ana L Lorenzo-Leal, Horacio Bach
{"title":"Nanomedicine-mediated drug delivery for potential treatment of inflammatory bowel disease: a narrative review.","authors":"Zhina Majdzadeh Ardekani, Ana L Lorenzo-Leal, Horacio Bach","doi":"10.2217/nnm-2023-0267","DOIUrl":"10.2217/nnm-2023-0267","url":null,"abstract":"<p><p><b>Background & aims:</b> Inflammatory bowel disease (IBD) is a condition characterized by chronic inflammation of the gastrointestinal tract, manifesting as either Crohn's disease (CrD) or ulcerative colitis (UC). Current treatment options for CrD and UC primarily focus on symptom management. In recent years, advancements in nanotechnology have increased the clinical applicability of nanoparticles (NPs) in treating IBD. This review explores the current research on NP-mediated drug-delivery systems for IBD treatment and assesses its advantages and limitations. <b>Results:</b> The authors examine diverse nanomedicine applications for IBD and address the current challenges and prospects in the field to advance nanomediated therapies in the future. <b>Conclusion:</b> Innovative NP-based treatment strategies promise a reliable and effective approach to IBD management.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139572263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidative stress-induced neurotoxicity of quantum dots and influencing factors. 量子点氧化应激诱导的神经毒性及其影响因素
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-04-12 DOI: 10.2217/nnm-2023-0326
Qing Fang, Meng Tang
{"title":"Oxidative stress-induced neurotoxicity of quantum dots and influencing factors.","authors":"Qing Fang, Meng Tang","doi":"10.2217/nnm-2023-0326","DOIUrl":"10.2217/nnm-2023-0326","url":null,"abstract":"<p><p>Quantum dots (QDs) have significant potential for treating and diagnosing CNS diseases. Meanwhile, the neurotoxicity of QDs has garnered attention. In this review, we focus on elucidating the mechanisms and consequences of CNS oxidative stress induced by QDs. First, we discussed the pathway of QDs transit into the brain. We then elucidate the relationship between QDs and oxidative stress from <i>in vivo</i> and <i>in vitro</i> studies. Furthermore, the main reasons and adverse outcomes of QDs leading to oxidative stress are discussed. In addition, the primary factors that may affect the neurotoxicity of QDs are analyzed. Finally, we propose potential strategies for mitigating QDs neurotoxicity and outline future perspectives for their development.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140870403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line. 开发和评估用于治疗 B16F10 黑色素瘤细胞系色素沉着的小檗碱负载 bigel。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-07-26 DOI: 10.1080/17435889.2024.2370759
Bharti Mangla, Pankaj Kumar, Zuber Ahamad, Shamama Javed, Waquar Ahsan, Geeta Aggarwal
{"title":"Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line.","authors":"Bharti Mangla, Pankaj Kumar, Zuber Ahamad, Shamama Javed, Waquar Ahsan, Geeta Aggarwal","doi":"10.1080/17435889.2024.2370759","DOIUrl":"10.1080/17435889.2024.2370759","url":null,"abstract":"<p><p><b>Aim:</b> The aim of this study was to optimize, develop, characterize and evaluate a topical nanobigel (BG) formulation containing Berberine (BRB) that exhibits anti-melanogenic properties.<b>Materials & methods:</b> The Berberine-loaded bigel (BRB@BG) formulation was prepared by homogenously mixing the optimized hydrogel and oleogel. BRB@BG was characterized <i>in vitro</i> and cytotoxicity study was conducted to evaluate its effects on murine skin melanoma B16F10 cell lines.<b>Results:</b> The optimized BRB@BG exhibited uniform texture with nanometric size, desirable spreadability and extrudability, suitable for topical applications. Cytotoxicity studies revealed that BRB@BG had a lower IC<sub>50</sub> value (4.84 μg/ml) on B16F10 cell lines compared with drug alone.<b>Conclusion:</b> In conclusion, the developed BRB@BG formulation showed good potential as safe and effective topical treatment for hyperpigmentation.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141763148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in nanostructured delivery systems for vancomycin. 万古霉素纳米结构给药系统的最新进展。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-08-15 DOI: 10.1080/17435889.2024.2377063
Mohabbat Ansari, Mohsen Shahlaei, Simzar Hosseinzadeh, Sajad Moradi
{"title":"Recent advances in nanostructured delivery systems for vancomycin.","authors":"Mohabbat Ansari, Mohsen Shahlaei, Simzar Hosseinzadeh, Sajad Moradi","doi":"10.1080/17435889.2024.2377063","DOIUrl":"10.1080/17435889.2024.2377063","url":null,"abstract":"<p><p>Despite the development of new generations of antibiotics, vancomycin remained as a high-efficacy antibiotic for treating the infections caused by MRSA. Researchers have explored various nanoformulations, aiming to enhance the therapeutic efficacy of vancomycin. Such novel formulations improve the effectiveness of drug cargoes in treating bacterial infections and minimizing the risk of adverse effects. The vast of researches have focuses on enhancing the permeation ability of vancomycin through different biological barriers especially those of gastrointestinal tract. Increasing the drug loading and tuning the drug release from nanocarrier are other important goal for many conducted studies. This study reviews the newest nano-based formulations for vancomycin as a key antibiotic in treating hospitalized bacterial infections.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141984129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antitumoral melatonin-loaded nanostructured lipid carriers. 抗肿瘤褪黑激素纳米脂质载体。
Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-08-02 DOI: 10.1080/17435889.2024.2379757
Lorena Bonilla-Vidal, Marta Świtalska, Marta Espina, Joanna Wietrzyk, Maria Luisa García, Eliana B Souto, Anna Gliszczyńska, Elena Sánchez-López
{"title":"Antitumoral melatonin-loaded nanostructured lipid carriers.","authors":"Lorena Bonilla-Vidal, Marta Świtalska, Marta Espina, Joanna Wietrzyk, Maria Luisa García, Eliana B Souto, Anna Gliszczyńska, Elena Sánchez-López","doi":"10.1080/17435889.2024.2379757","DOIUrl":"10.1080/17435889.2024.2379757","url":null,"abstract":"<p><p><b>Aim:</b> Cancer constitutes the second leading cause of death worldwide, with conventional therapies limited by significant side effects. Melatonin (MEL), a natural compound with antitumoral properties, suffers from instability and low solubility. To overcome these issues, MEL was encapsulated into nanostructured lipid carriers (MEL-NLC) containing rosehip oil to enhance stability and boost its antitumoral activity.<b>Methods:</b> MEL-NLC were optimized by a design of experiments approach and characterized for their physicochemical properties. Stability and biopharmaceutical behavior were assessed, along with interaction studies and <i>in vitro</i> antitumoral efficacy against various cancer cell lines.<b>Results:</b> Optimized MEL-NLC exhibited desirable physicochemical characteristics, including small particle size and sustained MEL release, along with long-term stability. <i>In vitro</i> studies demonstrated that MEL-NLC selectively induced cytotoxicity in several cancer cell lines while sparing healthy cells.<b>Conclusion:</b> MEL-NLC represent a promising alternative for cancer, combining enhanced stability and targeted antitumoral activity, potentially overcoming the limitations of conventional treatments.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信